312 related articles for article (PubMed ID: 26469347)
1. Epidemiological Interactions between Urogenital and Intestinal Human Schistosomiasis in the Context of Praziquantel Treatment across Three West African Countries.
Knowles SC; Webster BL; Garba A; Sacko M; Diaw OT; Fenwick A; Rollinson D; Webster JP
PLoS Negl Trop Dis; 2015; 9(10):e0004019. PubMed ID: 26469347
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
3. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
4. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review.
Kabuyaya M; Chimbari MJ; Mukaratirwa S
Infect Dis Poverty; 2018 Jul; 7(1):73. PubMed ID: 29986763
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials.
Zwang J; Olliaro PL
PLoS Negl Trop Dis; 2014; 8(11):e3286. PubMed ID: 25412105
[TBL] [Abstract][Full Text] [Related]
9. Bayesian risk mapping and model-based estimation of Schistosoma haematobium-Schistosoma mansoni co-distribution in Côte d'Ivoire.
Chammartin F; Houngbedji CA; Hürlimann E; Yapi RB; Silué KD; Soro G; Kouamé FN; N Goran EK; Utzinger J; Raso G; Vounatsou P
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3407. PubMed ID: 25522007
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
11. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period.
Senghor B; Diaw OT; Doucoure S; Sylla SN; Seye M; Talla I; Bâ CT; Diallo A; Sokhna C
Parasit Vectors; 2015 Jul; 8():362. PubMed ID: 26156522
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs.
Levecke B; Vlaminck J; Andriamaro L; Ame S; Belizario V; Degarege A; Engels D; Erko B; Garba AD; Kaatano GM; Mekonnen Z; Montresor A; Olliaro P; Pieri OS; Sacko M; Sam-Wobo SO; Tchuem Tchuenté LA; Webster JP; Vercruysse J
Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():183-187. PubMed ID: 33125936
[TBL] [Abstract][Full Text] [Related]
14. Urogenital schistosomiasis in three different water access in the Senegal river basin: prevalence and monitoring praziquantel efficacy and re-infection levels.
Senghor B; Mathieu-Begné E; Rey O; Doucouré S; Sow D; Diop B; Sène M; Boissier J; Sokhna C
BMC Infect Dis; 2022 Dec; 22(1):968. PubMed ID: 36581796
[TBL] [Abstract][Full Text] [Related]
15. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
[TBL] [Abstract][Full Text] [Related]
16. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children.
Stothard JR; Sousa-Figueiredo JC; Betson M; Green HK; Seto EY; Garba A; Sacko M; Mutapi F; Vaz Nery S; Amin MA; Mutumba-Nakalembe M; Navaratnam A; Fenwick A; Kabatereine NB; Gabrielli AF; Montresor A
Parasitology; 2011 Oct; 138(12):1593-606. PubMed ID: 21861945
[TBL] [Abstract][Full Text] [Related]
17. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
[TBL] [Abstract][Full Text] [Related]
18. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.
Touré S; Zhang Y; Bosqué-Oliva E; Ky C; Ouedraogo A; Koukounari A; Gabrielli AF; Bertrand S; Webster JP; Fenwick A
Bull World Health Organ; 2008 Oct; 86(10):780-7, A. PubMed ID: 18949215
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
[TBL] [Abstract][Full Text] [Related]
20. Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic community.
Asuming-Brempong EK; Ayi I; van der Puije W; Gyan BA; Larbi IA; Ashong Y; Frempong NA; Quartey JK; Otchere J; Jones FM; Wilson S; Dunne DW; Boakye DA
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010115. PubMed ID: 35263327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
